Alexandre Oseko Katayama
About Alexandre Oseko Katayama
Alexandre Oseko Katayama serves as the Supervisor of Bacterial Vaccines at Dechra Pharmaceuticals Plc and has held the position since 2018. He also works as a Supervisor of Production at Laboratórios Vencofarma Do Brasil Ltda., a role he has maintained since 2009.
Work at Dechra Pharmaceuticals
Alexandre Oseko Katayama has been employed at Dechra Pharmaceuticals Plc since 2018. He holds the position of Supervisor De Vacinas Bacterianas. His role involves overseeing the production and quality control of bacterial vaccines, ensuring compliance with industry standards and regulations. Dechra Pharmaceuticals is known for its focus on veterinary pharmaceuticals, and Alexandre contributes to the company's mission of providing high-quality healthcare solutions for animals.
Current Role at Laboratórios Vencofarma Do Brasil Ltda.
Since 2009, Alexandre Oseko Katayama has worked at Laboratórios Vencofarma Do Brasil Ltda. as Supervisor De Produção. In this capacity, he is responsible for managing production processes and ensuring that operations run efficiently. His experience in this role spans over 15 years, during which he has developed expertise in production management within the pharmaceutical sector.
Education and Expertise
Alexandre Oseko Katayama studied at Uel - Universidade Estadual De Londrina from 2004 to 2008, completing a four-year program. This educational background has equipped him with foundational knowledge and skills relevant to his roles in the pharmaceutical industry. His academic training supports his professional responsibilities in vaccine production and management.
Professional Background
Alexandre Oseko Katayama has built a career in the pharmaceutical industry, focusing on vaccine production. His professional journey began in 2009 at Laboratórios Vencofarma Do Brasil Ltda., where he has gained significant experience over the years. In 2018, he expanded his career by joining Dechra Pharmaceuticals Plc, further enhancing his expertise in bacterial vaccines.